Ajanta Pharma Ltd. (AJANTPHARM) Quarterly Results: Q1 FY27
Quick answer: Ajanta Pharma Ltd. (NSE: AJANTPHARM) reported Q1 FY27 revenue of ₹1,697 Cr and net profit of ₹334 Cr, with earnings per share (EPS) of ₹26.75, announced on 30-Jul-26.
That works out to a net profit margin of about 19.7% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Ajanta Pharma Ltd.'s Q1 FY27 results
Revenue of ₹1,697 Cr is what Ajanta Pharma Ltd. earned before costs. Net profit of ₹334 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 19.7%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
Ajanta Pharma Ltd. results FAQs
What were Ajanta Pharma Ltd.'s Q1 FY27 results?
Ajanta Pharma Ltd. (NSE: AJANTPHARM) reported Q1 FY27 revenue of ₹1,697 Cr and net profit of ₹334 Cr, with earnings per share (EPS) of ₹26.75, announced on 30-Jul-26.
What is Ajanta Pharma Ltd.'s EPS for Q1 FY27?
Ajanta Pharma Ltd.'s earnings per share for Q1 FY27 was ₹26.75. EPS is net profit divided by the number of outstanding shares.
When did Ajanta Pharma Ltd. announce its Q1 FY27 results?
Ajanta Pharma Ltd. announced its Q1 FY27 results on 30-Jul-26.
What is Ajanta Pharma Ltd.'s net profit margin?
On the reported figures, Ajanta Pharma Ltd.'s Q1 FY27 net profit margin is about 19.7% (net profit ÷ revenue).